Global Platelet Endothelial Cell Adhesion Molecule (PECAM) Protein Market: Current Status, In-depth Analysis and Forecast Outlook 2028

The global platelet endothelial cell adhesion molecule (PECAM) protein market is anticipated to grow at a CAGR of nearly 6.0% during the forecast period (2022-2028). Platelet endothelial cell adhesion molecule (PECAM) protein also known as cluster of differentiation 31 (CD31) is a protein that in humans is encoded by the PECAM1 gene found on chromosome17q23.3. The major factor expected to drive the market growth is the rising prevalence of cancer. PECAM protein has found its significance in diseases such as cancer (in a study it was found that elderly patients with gastric cancer have a high concentration of PECAM-1 in the serum which suggests that the use of a serum PECAM-1 level can be a good prognostic marker). In addition, the use of PECAM leads to a reduction of atherosclerotic lesions in mice), Disseminated intravascular coagulation, and Neuroinflammation along with that PECAM plays diverse roles in platelet function, thrombosis, vascular biology including roles in angiogenesis, mechanosensing of endothelial cell response to fluid shear stress, and regulation of multiple stages of leukocyte migration through venular walls.

Additionally, recent studies suggest a role for PECAM-1 in the inflammatory process and leukocyte-endothelial interaction. The process of leukocyte migration to the site of inflammation can be dissected into three successive stages, such as rolling, mediated by the selectins, tight adhesion mediated by Intercellular adhesion molecule (ICAMs), and transmigration of leukocytes through intercellular junctions of vascular endothelial cells. It also shows that it is an early and sensitive marker for tumor-induced angiogenesis. Some major players in the market include Thermo Fisher Scientific, Inc., Becton, Dickinson and Co., and Sino Biological Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

• Competitive Landscape- Thermo Fisher Scientific, Inc., Becton, Dickinson and Co., and Sino Biological Inc., among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Platelet Endothelial Cell Adhesion Molecule (PECAM) Protein Market Report by Segment

By Type

• Mouse
• Rabbit
• Others

By Application

• Laboratory
• Hospitals
• Others

Global Platelet Endothelial Cell Adhesion Molecule (PECAM) Protein Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa